Global Stem Cell Therapy Market: Investment & Growth Opportunity Analysis, 2019-2028
$2,800.00 – $5,440.00
The increasing prevalence of chronic diseases and growing developments in the stem cell therapies are driving the market growth
The rising prevalence of rare genetic illnesses is expected to fuel the expansion of the stem cell therapy market. Rare disorders such as thalassemia, phenylketonuria, cystic fibrosis, and others affect millions of individuals each year. According to World Health Organization (WHO), chronic diseases cause 41 million mortalities every year, equivalent to 71% of all mortalities globally. Traditional therapies and pharmaceuticals have proven ineffective in addressing various ailments, thereby, people are increasingly turning to advanced stem cell therapies, which will boost industry numbers.
Furthermore, developments in stem cell therapies that improve the pace of recovery in cancer patients are projected to increase their demand. Significant government funding and initiatives for regenerative medicine research and development activities in the developed region will further stimulate market growth. For instance, the Medical Research Future Fund (MRFF) announced the Stem Cell Therapies Mission as part of the 2019-20 budget. Nearly US$ 150 million was allocated by the Australian government to research and development of safe and effective medicines for all afflicted people.
Allogeneic stem cell therapy leads the global market
Allogeneic stem cell therapy is dominating the global stem cell therapy market in 2021 and is expected to continue to dominate the market over the forecast period. Allogeneic cells are widely used for the treatment of cancer due to their graft-versus-cancer effect. This effect enables immune system cells to cancer cells by using stem cells from the donor. The activated immune system response by the donor is relatively stronger than the recipient’s immune system.
Moreover, allogeneic stem cells are commonly used to treat various cancer types including lymphomas, leukemias, and myelomas. On the other hand, the autologous stem cell therapy segment is expected to grow at the highest growth rate during the forecast period as it is associated with fewer complications. Also, some of the other factors augmenting the segmental growth of the market include affordability, low risks, and a high survival rate of patients.
Increasing R&D activities and growing focus on regenerative medicines to aid market growth in North America
The North America stem cell therapy market is expected to grow significantly owing to the increased research and development initiatives by industry participants in the area. The Canadian government and JDRF Canada announced a new research funding of US$ 6 million in November 2020 to speed up stem cell-based therapeutics for type 1 diabetes. The favorable government actions and technological breakthroughs in regenerative medicine will further bolster regional market growth.
The stem cell therapy market is expected to develop significantly in Europe owing to an increase in the number of product approvals by regulatory bodies and the significant number of clinical trials in the region. The increasing focus of industry players and government entities on the development of stem cell therapies will further enhance the market growth. For instance, in January 2019, the Center for Beta Cell Therapy in Diabetes and ViaCyte Inc. announced a partnership for their first European clinical trial employing human stem cell-derived implants in T1D patients.
The stem cell therapy market in the Asia Pacific is expected to grow significantly, owing to an increase in the number of research programs and the establishment of new stem cell banks in the region. Further, the growing prevalence of chronic diseases is further augmenting the demand for advanced therapeutics such as stem cell therapies in the region. Additionally, an increase in the number of clinical studies for regenerative medicines, rising demand for organ transplantation, and the commercialization of regenerative medicine are all expected to improve Latin America’s stem cell industry. In the Middle East and Africa, rising healthcare infrastructure upgrades and increased research and development activities by prominent players would raise market demand.
Market Structure and Competitive Landscape
Some of the prominent players operating in the market include Celgene Corp. (Bristol Myers Squibb), ReNeuron Group PLC, BioTime Inc., Mesoblast Ltd., Seneca Biopharma Inc., Opexa Therapeutics Inc., Pluristem Therapeutics Inc., STEMCELL Technologies Inc., ThermoGenesis Holdings Inc., Astellas Pharma Inc., and Caladrius Biosciences Inc. among others. To grow their business, companies use techniques including new product launches, mergers and acquisitions, partnership and collaborations, etc.
- In March 2021, NOVADIP Biosciences S.A. gained FDA approval for its Investigational New Drug (IND) application for its autologous cell treatment product NVD-003. This strategy is expected to boost their market position by improving their product offerings and expanding their consumer base.
- In April 2020, Seneca Biopharma Inc. announced the completion of its new cell manufacturing facility in Suzhou, China. The company will manufacture NSI-566 in this new facility, which is the company’s leading stem cell therapy.
- In January 2020, Astellas Pharma Inc. signed a license agreement with Allele Biotechnology and Pharmaceuticals Inc., a cell-based medicines firm, with the goal of expanding Astellas’ access to Allele’s induced pluripotent stem cell (iPSC) technologies for various cell therapies.
Key Market Segmentation
RationalStat has segmented the global stem cell therapy market on the basis of product, therapy type, technology, therapeutic application, end use, and region.
- By Product
- Adult Stem Cells (ASCs)
- Hematopoietic
- Mesenchymal
- Neural
- Others (Epithelial/Skin)
- Human Embryonic Stem Cells (HESCs)
- Induced Pluripotent Stem Cells (iPSCs)
- Very Small Embryonic-Like Stem Cells
- Adult Stem Cells (ASCs)
- By Therapy Type
- Allogeneic Stem Cell Therapy
- Autologous Stem Cell Therapy
- By Technology
- Cell Acquisition
- Bone Marrow Harvest
- Umbilical Blood Cord
- Apheresis
- Cell Production
- Therapeutic Cloning
- In-vitro Fertilization
- Cell Culture
- Isolation
- Cryopreservation
- Expansion and Sub-Culture
- Cell Acquisition
- By Therapeutic Application
- Oncology
- Orthopedic
- Neurology
- Cardiovascular & Myocardial Infraction
- Hematology
- Others (Wounds & Injuries, Liver Disorders, Diabetes, etc.)
- By End Use
- Hospitals
- Research Organizations
- By Region
- North America
- US
- Canada
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Western Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Western Europe
- Eastern Europe
- Russia
- Poland
- Rest of Eastern Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- ASEAN (Indonesia, Vietnam, Malaysia, etc.)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- South Africa
- Turkey
- Rest of the Middle East & Africa
- North America
Research Methodology
RationalStat has developed a state-of-the-art research methodology to crunch numbers and provide the best possible real-time insights to clients. We combine a varied range of industry experience, data analytics, and experts’ viewpoint to create a research methodology for market sizing and forecasting.
RationalStat combines a mix of secondary sources as well as primary research to assess the market size and develop a forecast. Key steps involved in accurately deriving the market numbers are:
- Defining the problem by understanding the type of market and data required by the client.
- Data gathering and collection through relevant paid databases, publicly available sources, company reports, annual reports, surveys, and interviews.
- Formulating a hypothesis to create market numbers, forecast, influencing factors, and their relevance.
- Evaluating and analyzing the data by referring to data sources utilized and leveraged.
- Validating, interpreting, and finalizing the data by combining the details gathered from primary and secondary sources with the help of experienced analysts.
Secondary Sources
- Annual reports, company filings, investor presentations, product catalogs, white papers, research reports, trade fairs, and company documents.
- Available industry and market-related documents in the public domain.
- Paid database including Bloomberg, Factiva, S&P Capital IQ, FactSet, Refinitiv Eikon, ICIS, EUWID, Thomson Reuters, among others.
- Whitepapers, research papers, and industry blogs
Why Buy this Report?
The report is intended for stem cell therapy solutions manufacturers, healthcare organizations, medical research organizations, regulatory agencies, government organizations, and market research firms, among others. The report provides an in-depth analysis of market size, consumption pattern, ongoing market trends and challenges, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights to clients to find the right answers to their business questions.
Frequently Asked Questions (FAQs)
The global Stem Cell Therapy Market is expected to grow at a CAGR of approximately 9% during the forecast period 2022-2028.
The global market for Stem Cell Therapy was US$ 10.0 – 11.0 Billion in 2021.
One of the key trends in the market is the efficacy of stem cell therapy to treat patients with COVID-19.
North America is the leading region in the market.
Major companies operating in the global Stem Cell Therapy Market are Celgene Corp. (Bristol Myers Squibb), ReNeuron Group PLC, Mesoblast Ltd., and Seneca Biopharma Inc., and STEMCELL Technologies Inc. among others.
| REGION | Global |
|---|---|
| RELEASE YEAR | 2022 |
| RESEARCH CODE | RST-SAR-032 |
| ADDITIONAL FEATURE | 24×7 Post sales support and 15% free customization |
| User License | Single User/Team License, Corporate License |
Table of Contents
1. Market Introduction
1.1. Scope of Study
1.2. Problem Statement
1.3. Market Segmentation
2. Assumptions and Acronyms
3. Executive Summary
3.1. Global Market in 2022
3.2. Analyst Insights & Recommendations
3.3. Growth Opportunities and Key Strategies
3.4. Supply-side and Demand-side Trends
4. Research Methodology
5. Analysis of COVID-19 Impact and Road Ahead
6. Market Indicators and Background
6.1. Macro-Economic Factors
6.1.1. Global Population Overview and Forecast
6.1.2. Global Stem Cell Therapy Professionals in the select countries
6.2. Forecasting Factors
Robust assessment of various factors including industrial performance, healthcare expenditures, industry players’ expenditures, economic conditions, among others
6.3. Supply Chain & Value Chain Analysis
6.4. Industry SWOT Analysis
6.5. PESTLE Analysis
6.6. Porter’s Five Forces Analysis
7. Government Laws and Industry Regulations
8. Global and Regional Market Dynamics
8.1. Drivers
8.2. Restraints
8.3. Trends
8.4. Opportunities
9. Global Stem Cell Therapy Market: Key Investment Analysis
9.1. By Key Industry Players
9.2. By Therapy Type
9.3. By Therapeutic Application
9.4. By Region
9.5. M&A Activities
Robust assessment of major investments made by various industry players along with key therapeutic application areas, therapy type, and key region
10. Pricing Analysis
10.1. By Therapy Type
10.1.1. Allogeneic Stem Cell Therapy
10.1.2. Autologous Stem Cell Therapy
10.2. By Region
10.2.1. North America
10.2.2. Western Europe
10.2.3. Eastern Europe
10.2.4. Asia Pacific
10.2.5. Latin America
10.2.6. Middle East & Africa
11. Parent Market Overview: Global Healthcare & Life Sciences Market
12. Segmental Analysis
12.1. Global Stem Cell Therapy Market by Product
12.1.1. Segment Overview
12.1.1.1. Adult Stem Cells (ASCs)
12.1.1.1.1. Hematopoietic
12.1.1.1.2. Mesenchymal
12.1.1.1.3. Neural
12.1.1.1.4. Others (Epithelial/Skin)
12.1.1.2. Human Embryonic Stem Cells (HESCs)
12.1.1.3. Induced Pluripotent Stem Cells (iPSCs)
12.1.1.4. Very Small Embryonic-Like Stem Cells
12.2. Global Stem Cell Therapy Market by Therapy Type
12.2.1. Segment Overview
12.2.1.1. Allogeneic Stem Cell Therapy
12.2.1.2. Autologous Stem Cell Therapy
12.3. Global Stem Cell Therapy Market by Technology
12.3.1. Segment Overview
12.3.1.1. Cell Acquisition
12.3.1.1.1. Bone Marrow Harvest
12.3.1.1.2. Umbilical Blood Cord
12.3.1.1.3. Apheresis
12.3.1.2. Cell Production
12.3.1.2.1. Therapeutic Cloning
12.3.1.2.2. In-vitro Fertilization
12.3.1.2.3. Cell Culture
12.3.1.2.4. Isolation
12.3.1.3. Cryopreservation
12.3.1.4. Expansion and Sub-Culture
12.4. Global Stem Cell Therapy Market by Therapeutic Application
12.4.1. Segment Overview
12.4.1.1. Oncology
12.4.1.2. Orthopedic
12.4.1.3. Neurology
12.4.1.4. Cardiovascular & Myocardial Infraction
12.4.1.5. Hematology
12.4.1.6. Others (Wounds & Injuries, Liver Disorders, Diabetes, etc.)
12.5. Global Stem Cell Therapy Market by End Use
12.5.1. Segment Overview
12.5.1.1. Hospitals
12.5.1.2. Research Organizations
12.6. Global Stem Cell Therapy Market by Region
12.6.1. North America
12.6.2. Latin America
12.6.3. Western Europe
12.6.4. Eastern Europe
12.6.5. Asia Pacific
12.6.6. Middle East & Africa
13. Regional Analysis
13.1. North America Stem Cell Therapy Market Analysis and Forecast 2019-2028
13.1.1. Regional Market Overview and Key Takeaways
13.1.2. North America Stem Cell Therapy Market by Product
13.1.3. North America Stem Cell Therapy Market by Therapy Type
13.1.4. North America Stem Cell Therapy Market by Technology
13.1.5. North America Stem Cell Therapy Market by Therapeutic Application
13.1.6. North America Stem Cell Therapy Market by End Use
13.1.6.1. US
13.2. Latin America Stem Cell Therapy Market Analysis and Forecast 2019-2028
13.2.1. Regional Market Overview and Key Takeaways
13.2.2. Latin America Stem Cell Therapy Market by Product
13.2.3. Latin America Stem Cell Therapy Market by Therapy Type
13.2.4. Latin America Stem Cell Therapy Market by Technology
13.2.5. Latin America Stem Cell Therapy Market by Therapeutic Application
13.2.6. Latin America Stem Cell Therapy Market by End Use
13.2.6.1. Brazil
13.2.6.2. Mexico
13.2.6.3. Rest of Latin America
13.3. Western Europe Stem Cell Therapy Market Analysis and Forecast 2019-2028
13.3.1. Regional Market Overview and Key Takeaways
13.3.2. Western Europe Stem Cell Therapy Market by Product
13.3.3. Western Europe Stem Cell Therapy Market by Therapy Type
13.3.4. Western Europe Stem Cell Therapy Market by Technology
13.3.5. Western Europe Stem Cell Therapy Market by Therapeutic Application
13.3.6. Western Europe Stem Cell Therapy Market by End Use
13.3.6.1. Germany
13.3.6.2. UK
13.3.6.3. France
13.3.6.4. Spain
13.3.6.5. Italy
13.3.6.6. Benelux
13.3.6.7. Nordic
13.3.6.8. Rest of Western Europe
13.4. Eastern Europe Stem Cell Therapy Market Analysis and Forecast 2019-2028
13.4.1. Regional Market Overview and Key Takeaways
13.4.2. Eastern Europe Stem Cell Therapy Market by Product
13.4.3. Eastern Europe Stem Cell Therapy Market by Therapy Type
13.4.4. Eastern Europe Stem Cell Therapy Market by Technology
13.4.5. Eastern Europe Stem Cell Therapy Market by Therapeutic Application
13.4.6. Eastern Europe Stem Cell Therapy Market by End Use
13.4.6.1. Russia
13.4.6.2. Poland
13.4.6.3. Rest of Eastern Europe
13.5. Asia Pacific Stem Cell Therapy Market Analysis and Forecast 2019-2028
13.5.1. Regional Market Overview and Key Takeaways
13.5.2. Asia Pacific Stem Cell Therapy Market by Product
13.5.3. Asia Pacific Stem Cell Therapy Market by Therapy Type
13.5.4. Asia Pacific Stem Cell Therapy Market by Technology
13.5.5. Asia Pacific Stem Cell Therapy Market by Therapeutic Application
13.5.6. Asia Pacific Stem Cell Therapy Market by End Use
13.5.6.1. China
13.5.6.2. Japan
13.5.6.3. India
13.5.6.4. South Korea
13.5.6.5. Australia
13.5.6.6. ASEAN
13.5.6.7. Rest of Asia-Pacific
13.6. Middle East & Africa Stem Cell Therapy Market Analysis and Forecast 2019-2028
13.6.1. Regional Market Overview and Key Takeaways
13.6.2. Middle East & Africa Stem Cell Therapy Market by Product
13.6.3. Middle East & Africa Stem Cell Therapy Market by Therapy Type
13.6.4. Middle East & Africa Stem Cell Therapy Market by Technology
13.6.5. Middle East & Africa Stem Cell Therapy Market by Therapeutic Application
13.6.6. Middle East & Africa Stem Cell Therapy Market by End Use
13.6.6.1. GCC
13.6.6.2. South Africa
13.6.6.3. Turkey
13.6.6.4. Rest of the Middle East & Africa
14. Competitive Landscape
14.1. Competition Dashboard
14.1.1. Global and Regional Market Share Analysis
14.1.2. Market Structure
14.2. Competitive Benchmarking
14.3. Key Strategy Analysis
14.4. Company Profiles
14.4.1. Celgene Corp. (Bristol Myers Squibb)
14.4.1.1. Company Overview
14.4.1.2. Product/Service Offerings
14.4.1.3. Key Financials
14.4.1.4. Recent Developments
14.4.2. ReNeuron Group PLC
14.4.2.1. Company Overview
14.4.2.2. Product/Service Offerings
14.4.2.3. Financials
14.4.2.4. Recent Developments
14.4.3. BioTime Inc.
14.4.3.1. Company Overview
14.4.3.2. Product/Service Offerings
14.4.3.3. Financials
14.4.3.4. Recent Developments
14.4.4. Mesoblast Ltd.
14.4.4.1. Company Overview
14.4.4.2. Product/Service Offerings
14.4.4.3. Financials
14.4.4.4. Recent Developments
14.4.5. Seneca Biopharma Inc.
14.4.5.1. Company Overview
14.4.5.2. Product/Service Offerings
14.4.5.3. Financials
14.4.5.4. Recent Developments
14.4.6. Opexa Therapeutics Inc.
14.4.6.1. Company Overview
14.4.6.2. Product/Service Offerings
14.4.6.3. Financials
14.4.6.4. Recent Developments
14.4.7. Pluristem Therapeutics Inc.
14.4.7.1. Company Overview
14.4.7.2. Product/Service Offerings
14.4.7.3. Financials
14.4.7.4. Recent Developments
14.4.8. STEMCELL Technologies Inc.
14.4.8.1. Company Overview
14.4.8.2. Product/Service Offerings
14.4.8.3. Financials
14.4.8.4. Recent Developments
14.4.9. ThermoGenesis Holdings Inc.
14.4.9.1. Company Overview
14.4.9.2. Product/Service Offerings
14.4.9.3. Financials
14.4.9.4. Recent Developments
14.4.10. Astellas Pharma Inc.
14.4.10.1. Company Overview
14.4.10.2. Product/Service Offerings
14.4.10.3. Financials
14.4.10.4. Recent Developments
14.4.11. Caladrius Biosciences Inc.
14.4.11.1. Company Overview
14.4.11.2. Product/Service Offerings
14.4.11.3. Financials
14.4.11.4. Recent Developments
14.4.12. NOVADIP Biosciences S.A.
14.4.12.1. Company Overview
14.4.12.2. Product/Service Offerings
14.4.12.3. Financials
14.4.12.4. Recent Developments
A comprehensive list of stem cell therapy providers will be provided along with geographical reach, employee count, revenue, product capacities, and their capabilities
15. Disclaimer
List of Figures/Tables
List of Figures
Figure 01: Global Stem Cell Therapy Market Value Analysis (US$ Mn), 2019-2021
Figure 02: Global Stem Cell Therapy Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2022–2028
Figure 03: Global Stem Cell Therapy Market Size and Market Share Analysis (%) by Product, 2022 & 2028
Figure 04: Global Stem Cell Therapy Market Y-o-Y Analysis (%) by Product, 2022-2028
Figure 05: Global Stem Cell Therapy Market Size and Market Share Analysis (%) by Therapy Type, 2022 & 2028
Figure 06: Global Stem Cell Therapy Market Y-o-Y Analysis (%) by Therapy Type, 2022-2028
Figure 07: Global Stem Cell Therapy Market Size and Market Share Analysis (%) by Technology, 2022 & 2028
Figure 08: Global Stem Cell Therapy Market Y-o-Y Analysis (%) by Technology, 2022-2028
Figure 09: Global Stem Cell Therapy Market Size and Market Share Analysis (%) by Therapeutic Application, 2022 & 2028
Figure 10: Global Stem Cell Therapy Market Y-o-Y Analysis (%) by Therapeutic Application, 2022-2028
Figure 09: Global Stem Cell Therapy Market Size and Market Share Analysis (%) by End Use, 2022 & 2028
Figure 10: Global Stem Cell Therapy Market Y-o-Y Analysis (%) by End Use, 2022-2028
Figure 11: Global Stem Cell Therapy Market Size and Market Share Analysis (%) by Region, 2022 & 2028
Figure 12: Global Stem Cell Therapy Market Y-o-Y Growth (%) by Region, 2022–2028
Figure 13: North America Stem Cell Therapy Market Size and Market Share Analysis (%) by Product, 2022 & 2028
Figure 14: North America Stem Cell Therapy Market Size and Market Share Analysis (%) by Therapy Type, 2022 & 2028
Figure 15: North America Stem Cell Therapy Market Size and Market Share Analysis (%) by Technology, 2022 & 2028
Figure 16: North America Stem Cell Therapy Market Size and Market Share Analysis (%) by Therapeutic Application, 2022 & 2028
Figure 16: North America Stem Cell Therapy Market Size and Market Share Analysis (%) by End Use, 2022 & 2028
Figure 17: North America Stem Cell Therapy Market Size and Market Share Analysis (%) by Country, 2022 & 2028
Figure 18: Latin America Stem Cell Therapy Market Size and Market Share Analysis (%) by Product, 2022 & 2028
Figure 19: Latin America Stem Cell Therapy Market Size and Market Share Analysis (%) by Therapy Type, 2022 & 2028
Figure 20: Latin America Stem Cell Therapy Market Size and Market Share Analysis (%) by Technology, 2022 & 2028
Figure 21: Latin America Stem Cell Therapy Market Size and Market Share Analysis (%) by Therapeutic Application, 2022 & 2028
Figure 21: Latin America Stem Cell Therapy Market Size and Market Share Analysis (%) by End Use, 2022 & 2028
Figure 22: Latin America Stem Cell Therapy Market Size and Market Share Analysis (%) by Country, 2022 & 2028
Figure 23: Western Europe Stem Cell Therapy Market Size and Market Share Analysis (%) by Product, 2022 & 2028
Figure 24: Western Europe Stem Cell Therapy Market Size and Market Share Analysis (%) by Therapy Type, 2022 & 2028
Figure 25: Western Europe Stem Cell Therapy Market Size and Market Share Analysis (%) by Technology, 2022 & 2028
Figure 26: Western Europe Stem Cell Therapy Market Size and Market Share Analysis (%) by Therapeutic Application, 2022 & 2028
Figure 26: Western Europe Stem Cell Therapy Market Size and Market Share Analysis (%) by End Use, 2022 & 2028
Figure 27: Western Europe Stem Cell Therapy Market Size and Market Share Analysis (%) by Country, 2022 & 2028
Figure 28: Eastern Europe Stem Cell Therapy Market Size and Market Share Analysis (%) by Product, 2022 & 2028
Figure 29: Eastern Europe Stem Cell Therapy Market Size and Market Share Analysis (%) by Therapy Type, 2022 & 2028
Figure 30: Eastern Europe Stem Cell Therapy Market Size and Market Share Analysis (%) by Technology, 2022 & 2028
Figure 31: Eastern Europe Stem Cell Therapy Market Size and Market Share Analysis (%) by Therapeutic Application, 2022 & 2028
Figure 31: Eastern Europe Stem Cell Therapy Market Size and Market Share Analysis (%) by End Use, 2022 & 2028
Figure 32: Eastern Europe Stem Cell Therapy Market Size and Market Share Analysis (%) by Country, 2022 & 2028
Figure 33: Asia Pacific Stem Cell Therapy Market Size and Market Share Analysis (%) by Product, 2022 & 2028
Figure 34: Asia Pacific Stem Cell Therapy Market Size and Market Share Analysis (%) by Therapy Type, 2022 & 2028
Figure 35: Asia Pacific Stem Cell Therapy Market Size and Market Share Analysis (%) by Technology, 2022 & 2028
Figure 36: Asia Pacific Stem Cell Therapy Market Size and Market Share Analysis (%) by Therapeutic Application, 2022 & 2028
Figure 36: Asia Pacific Stem Cell Therapy Market Size and Market Share Analysis (%) by End Use, 2022 & 2028
Figure 37: Asia Pacific Stem Cell Therapy Market Size and Market Share Analysis (%) by Country, 2022 & 2028
Figure 38: Middle East & Africa Stem Cell Therapy Market Size and Market Share Analysis (%) by Product, 2022 & 2028
Figure 39: Middle East & Africa Stem Cell Therapy Market Size and Market Share Analysis (%) by Therapy Type, 2022 & 2028
Figure 40: Middle East & Africa Stem Cell Therapy Market Size and Market Share Analysis (%) by Technology, 2022 & 2028
Figure 41: Middle East & Africa Stem Cell Therapy Market Size and Market Share Analysis (%) by Therapeutic Application, 2022 & 2028
Figure 41: Middle East & Africa Stem Cell Therapy Market Size and Market Share Analysis (%) by End Use, 2022 & 2028
Figure 42: Middle East & Africa Stem Cell Therapy Market Size and Market Share Analysis (%) by Country, 2022 & 2028
List of Tables
Table 1: Global Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Product
Table 2: Global Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Therapy Type
Table 3: Global Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Technology
Table 4: Global Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Therapeutic Application
Table 5: Global Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End Use
Table 6: Global Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Region
Table 7: North America Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Product
Table 8: North America Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Therapy Type
Table 9: North America Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Technology
Table 10: North America Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Therapeutic Application
Table 11: North America Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End Use
Table 12: North America Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 13: Latin America Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Product
Table 14: Latin America Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Therapy Type
Table 15: Latin America Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Technology
Table 16: Latin America Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Therapeutic Application
Table 17: Latin America Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End Use
Table 18: Latin America Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 19: Western Europe Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Product
Table 20: Western Europe Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Therapy Type
Table 21: Western Europe Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Technology
Table 22: Western Europe Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Therapeutic Application
Table 23: Western Europe Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End Use
Table 24: Western Europe Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 25: Eastern Europe Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Product
Table 26: Eastern Europe Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Therapy Type
Table 27: Eastern Europe Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Technology
Table 28: Eastern Europe Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Therapeutic Application
Table 29: Eastern Europe Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End Use
Table 30: Eastern Europe Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 31: Asia Pacific Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Product
Table 32: Asia Pacific Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Therapy Type
Table 33: Asia Pacific Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Technology
Table 34: Asia Pacific Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Therapeutic Application
Table 35: Asia Pacific Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End Use
Table 36: Asia Pacific Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 37: Middle East & Africa Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Product
Table 38: Middle East & Africa Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Therapy Type
Table 39: Middle East & Africa Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Technology
Table 40: Middle East & Africa Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Therapeutic Application
Table 41: Middle East & Africa Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End Use
Table 42: Middle East & Africa Stem Cell Therapy Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Every Sample Includes
Research Methodology
Complete Table of Contents, List of Charts and Tables
Exclusive Facts & Illustrations
Related products
Healthcare & Pharmaceutical
Global mRNA Technology Market: Investment & Growth Opportunity Analysis, 2020-2030
Increasing investments and R&D activities in mRNA-based technologies are fueling the market growth
Healthcare & Pharmaceutical
Global Molecular Diagnostic Market Analysis and Forecast 2019-2028
Growing demand for personalized medicine coupled with technological advancement is expected to further drive the demand for molecular diagnostics
Healthcare & Pharmaceutical
Global Clinical Diagnostics Market Analysis and Forecast 2019-2028
The increasing healthcare spending and technological advancements are expected to drive the market revenue
Healthcare & Pharmaceutical
Global Pharmaceutical Sterility Testing Market Analysis and Forecast 2019-2028
Growth in the pharmaceuticals and biotechnology industry driving the pharmaceutical sterility testing market
Healthcare & Pharmaceutical
Global Osteoporosis Treatment Market Analysis and Forecast 2019-2028
Market Introduction: Key Takeaways The global osteoporosis treatment market is expected to grow at a CAGR of 4.8% during the forecast period of 2023-2028, according to a RationalStat market report. Osteoporosis is a condition characterized by low bone density and increased risk of fractures, and it is a significant global health concern, particularly among the [...]
Healthcare & Pharmaceutical
Global Healthcare Information System (HIS) Market Analysis and Forecast 2019-2028
Increasing adoption of IT solutions in healthcare facilities to enhance efficiency is fueling the market growth